Sign In  |  Register  |  About San Rafael  |  Contact Us

San Rafael, CA
September 01, 2020 1:37pm
7-Day Forecast | Traffic
  • Search Hotels in San Rafael

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Propelling Neuroscience Research with Creative Biolabs’ Innovative Solutions

By: Get News
Contract research organization (CRO) Creative Biolabs is pleased to announce a new portfolio of high-quality services to support neurological disease research for pharmaceutical companies around the world.

New York, USA - October 23, 2024 - Current studies in neuroscience focus on neuroinflammation, synaptic plasticity, neural circuits, and their roles in behavior and cognition. Using techniques like high-content screening, stem cell models, and advanced imaging, researchers can uncover insights into brain function and disorders. As an organization that subscribes to creativity, Creative Biolabs never shies away from providing the scientific community with the relevant tools needed to overcome the challenges in the wider area of neuroscience.

"A long-term goal you'll see accomplished with our innovative solutions is moving the development of new clinical solutions from bench research to clinical applications. In that mission, we provide loud assistance to pharmaceutical companies and support advanced research areas," according to one of Creative Biolabs' scientists.

One of the highlighted services at Creative Biolabs is astrocyte differentiation technology, which can rapidly and efficiently generate human astrocytes of high quality in terms of morphology, molecule profile, and function.

"In addition, custom astrocyte differentiation services are available at our company to global clients to facilitate their research," added the scientist.

"High-content screening (HCS) is an invaluable tool for drug discovery and toxicology studies, enabling the detailed analysis of cellular responses to various compounds," stated the director of this company. "Powered by our STEMODâ„¢ platform, Creative Biolabs' high-content screening system enables high throughput and data acquisition rapidly."

Renowned for advanced HCS solutions, Creative Biolabs provides high-content screening based on stem cell models, efficiently analyzing stem cell differentiation under a large variety of conditions.

Another highlighted solution is the complement-related testing approach. Understanding the complement system is essential for studying various diseases, including autoimmune disorders, infections, and neurodegenerative conditions. Creative Biolabs has been dedicated to complement assays for years and supports complement research related to neurological diseases.

"Our scientists expanded testing offerings, including complement function/activity tests and complement multiplex assays, supporting the development of complement-targeted therapies and enhancing the knowledge of complement-related diseases," said the scientist.

The complement multiplex assay offered by Creative Biolabs allows multiple complement components to be measured in a single sample at the same time, which is a very convenient and economical approach for the researchers.

For more information about innovative services and products at Creative Biolabs, please visit https://neuros.creative-biolabs.com.

About Creative Biolabs

With the evolving changes in the field of neuroscience, Creative Biolabs strives to assist researchers in overcoming the obstacles faced in neurological disease research. In collaboration with a team of specialists devoted to the development of science, the company provides professional services for neurobiology and further activities.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://neuros.creative-biolabs.com



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 SanRafael.com & California Media Partners, LLC. All rights reserved.